Trials / Unknown
UnknownNCT03466541
Workplace Interventions Preventing Risky Use of Alcohol and Sick Leave
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- University of Stavanger · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The aim of this study is to investigate the effectiveness of two workplace interventions (the Riskbruk model and Balance) in reducing risky alcohol consumption, sickness absence and presenteeism. The purpose is to assess whether the Riskbruk model should be implemented in the Norwegian workforce in its entirety, whether the less extensive and costly alternative Balance is sufficient, or if neither one of them show effectiveness compared to usual care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Riskbruk | The Riskbruk model incorporates alcohol screening through a widely employed alcohol screening questionnaire, the Alcohol Use Disorders Identification Test (AUDIT) and a standard alcohol biomarker, carbohydrate-deficient transferring in serum (CDT), with brief consultations using the motivational interviewing (MI) technique. MI is a collaborative conversation style used to increase awareness and reflection around one's own drinking habits, as well as strengthening the person's motivation for a lifestyle change. The conversation style includes expressing empathy through reflective listening, communicating respect and acceptance of the participants and their feelings, and open up for self-reflection and exploration around the drinking behaviour. |
| BEHAVIORAL | Balance | Balance is a new Norwegian eHealth programme, and incorporates two approaches to behaviour modification interventions: a brief interventions and an intensive self-help programme. The intervention is based on cognitive-behavioural and self-help principles, and is given to the participants through multiple interactive sessions. |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2018-03-15
- Last updated
- 2022-11-28
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT03466541. Inclusion in this directory is not an endorsement.